Pill Box
June 24, 2005
Recalls of popular drugs like Vioxx and Celebrex raise questions about how smart it is for drug companies to bypass doctors and hawk their wares directly to consumers on TV. Some claim the $4 billion spent annually on the ads increase awareness of treatments; others say the result is an overmedicated public clamoring for pills. Brooke consults with Jim Davidson, counsel to the Advertising Coalition, about the ethics of direct-to-consumer ads.
